rs532545
From SNPedia
Orientation | minus |
Stabilized | minus |
Geno | Mag | Summary |
---|---|---|
(G;G) | 0 | common/normal |
Make rs532545(A;A) |
Make rs532545(A;G) |
Reference | GRCh38 38.1/141 |
Chromosome | 1 |
Position | 20588679 |
Gene | CDA |
is a | snp |
is | mentioned by |
dbSNP | rs532545 |
dbSNP (classic) | rs532545 |
ClinGen | rs532545 |
ebi | rs532545 |
HLI | rs532545 |
Exac | rs532545 |
Gnomad | rs532545 |
Varsome | rs532545 |
LitVar | rs532545 |
Map | rs532545 |
PheGenI | rs532545 |
Biobank | rs532545 |
1000 genomes | rs532545 |
hgdp | rs532545 |
ensembl | rs532545 |
geneview | rs532545 |
scholar | rs532545 |
rs532545 | |
pharmgkb | rs532545 |
gwascentral | rs532545 |
openSNP | rs532545 |
23andMe | rs532545 |
SNPshot | rs532545 |
SNPdbe | rs532545 |
MSV3d | rs532545 |
GWAS Ctlg | rs532545 |
GMAF | 0.2057 |
Max Magnitude | 0 |
? | (A;A) (A;G) (G;G) | 28 |
---|---|---|
|
[PMID 21325291] A polymorphism in the cytidine deaminase promoter predicts severe capecitabine-induced hand-foot syndrome.
[PMID 26174689] The influence of cytidine deaminase -33delC polymorphism on treatment outcome with high-dose cytarabine in Chinese patients with relapsed acute myeloid leukaemia